Study Stopped
PI has left UHN. This study is no longer running at UHN.
Design and Evaluation of Mobile X-ray for Rapid and Accurate Diagnosis of Thoracic Disease
Design and Evaluation of Innovative Mobile X-Ray Technology for Rapid and Accurate Diagnosis of Thoracic Disease in Critically Ill Patients
1 other identifier
interventional
34
1 country
1
Brief Summary
Computed tomography (CT) is the most accurate test for evaluating patients with thoracic disease. However, access to CT is limited due to long wait times and for the sickest patients in Hospital who cannot be transported from the ward to the CT scanner. The investigators propose to modify a standard X-ray unit to provide more detailed information of the chest such that a CT scan is not required for all patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2015
CompletedFirst Submitted
Initial submission to the registry
March 12, 2015
CompletedFirst Posted
Study publicly available on registry
March 18, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedOctober 25, 2018
October 1, 2018
1.8 years
March 12, 2015
October 23, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Improved detection of maliganancy with modified x-ray
6 months
Study Arms (2)
Digital Tomosynthesis
OTHERPatient will get tomosynthesis scan
Dual energy
OTHERPatient will get dual energy scan
Interventions
Eligibility Criteria
You may qualify if:
- the presence of lung disease (nodules, masses, consolidation and collapse), pleural disease (effusion, thickening), mediastinal and hilar lymph node enlargement, on thoracic CT
You may not qualify if:
- unable to consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Health Network, Torontolead
- Carestream Health, Inc.collaborator
Study Sites (1)
Toronto General Hospital, Department of Medical Imaging
Toronto, Ontario, M5G 2N2, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Narinder Paul, MD
UHN
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 12, 2015
First Posted
March 18, 2015
Study Start
March 1, 2015
Primary Completion
December 1, 2016
Study Completion
December 1, 2016
Last Updated
October 25, 2018
Record last verified: 2018-10